256 related articles for article (PubMed ID: 26896154)
1. Genetic analysis of intestinal polyp development in Collaborative Cross mice carrying the Apc (Min/+) mutation.
Dorman A; Baer D; Tomlinson I; Mott R; Iraqi FA
BMC Genet; 2016 Feb; 17():46. PubMed ID: 26896154
[TBL] [Abstract][Full Text] [Related]
2. Genetic mapping of novel modifiers for Apc
Dorman A; Binenbaum I; Abu-Toamih Atamni HJ; Chatziioannou A; Tomlinson I; Mott R; Iraqi FA
BMC Genomics; 2021 Jul; 22(1):566. PubMed ID: 34294033
[TBL] [Abstract][Full Text] [Related]
3. Identification of five novel modifier loci of Apc(Min) harbored in the BXH14 recombinant inbred strain.
Nnadi SC; Watson R; Innocent J; Gonye GE; Buchberg AM; Siracusa LD
Carcinogenesis; 2012 Aug; 33(8):1589-97. PubMed ID: 22637734
[TBL] [Abstract][Full Text] [Related]
4. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia.
Silverman KA; Koratkar R; Siracusa LD; Buchberg AM
Genome Res; 2002 Jan; 12(1):88-97. PubMed ID: 11779834
[TBL] [Abstract][Full Text] [Related]
5. Reduction in alkaline sphingomyelinase in colorectal tumorigenesis is not related to the APC gene mutation.
Hertervig E; Nilsson A; Nilbert M; Duan RD
Int J Colorectal Dis; 2003 Jul; 18(4):309-13. PubMed ID: 12774245
[TBL] [Abstract][Full Text] [Related]
6. Analysis of reciprocal congenic lines reveals the C3H/HeJ genome to be highly resistant to ApcMin intestinal tumorigenesis.
Koratkar R; Silverman KA; Pequignot E; Hauck WW; Buchberg AM; Siracusa LD
Genomics; 2004 Nov; 84(5):844-52. PubMed ID: 15475263
[TBL] [Abstract][Full Text] [Related]
7. Resistant carbohydrates stimulate cell proliferation and crypt fission in wild-type mice and in the Apc(Min/+) mouse model of intestinal cancer, association with enhanced polyp development.
Mandir N; Englyst H; Goodlad RA
Br J Nutr; 2008 Oct; 100(4):711-21. PubMed ID: 18279550
[TBL] [Abstract][Full Text] [Related]
8. Genetic dissection of the Mom5 modifier locus and evaluation of Mom5 candidate genes.
Otterpohl KL; Gould KA
Mamm Genome; 2015 Jun; 26(5-6):235-47. PubMed ID: 25976411
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutations of the adenomatous polyposis coli gene in gastroduodenal tumors from patients with familial adenomatous polyposis.
Toyooka M; Konishi M; Kikuchi-Yanoshita R; Iwama T; Miyaki M
Cancer Res; 1995 Jul; 55(14):3165-70. PubMed ID: 7606737
[TBL] [Abstract][Full Text] [Related]
10. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
Lee J; Hargest R; Wasan H; Phillips RK
Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
[TBL] [Abstract][Full Text] [Related]
11. Identification of Mom12 and Mom13, two novel modifier loci of Apc (Min) -mediated intestinal tumorigenesis.
Crist RC; Roth JJ; Lisanti MP; Siracusa LD; Buchberg AM
Cell Cycle; 2011 Apr; 10(7):1092-9. PubMed ID: 21386660
[TBL] [Abstract][Full Text] [Related]
12. The CAST/Ei strain confers significant protection against Apc(Min) intestinal polyps, independent of the resistant modifier of Min 1 (Mom1) locus.
Koratkar R; Pequignot E; Hauck WW; Siracusa LD
Cancer Res; 2002 Oct; 62(19):5413-7. PubMed ID: 12359746
[TBL] [Abstract][Full Text] [Related]
13. Understanding phenotypic variation in rodent models with germline Apc mutations.
Zeineldin M; Neufeld KL
Cancer Res; 2013 Apr; 73(8):2389-99. PubMed ID: 23580574
[TBL] [Abstract][Full Text] [Related]
14. Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice.
Yamada Y; Hata K; Hirose Y; Hara A; Sugie S; Kuno T; Yoshimi N; Tanaka T; Mori H
Cancer Res; 2002 Nov; 62(22):6367-70. PubMed ID: 12438216
[TBL] [Abstract][Full Text] [Related]
15. APC in the regulation of intestinal crypt fission.
Wasan HS; Park HS; Liu KC; Mandir NK; Winnett A; Sasieni P; Bodmer WF; Goodlad RA; Wright NA
J Pathol; 1998 Jul; 185(3):246-55. PubMed ID: 9771477
[TBL] [Abstract][Full Text] [Related]
16. Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis.
Groves C; Lamlum H; Crabtree M; Williamson J; Taylor C; Bass S; Cuthbert-Heavens D; Hodgson S; Phillips R; Tomlinson I
Am J Pathol; 2002 Jun; 160(6):2055-61. PubMed ID: 12057910
[TBL] [Abstract][Full Text] [Related]
17. The armadillo repeat domain of Apc suppresses intestinal tumorigenesis.
Crist RC; Roth JJ; Baran AA; McEntee BJ; Siracusa LD; Buchberg AM
Mamm Genome; 2010 Oct; 21(9-10):450-7. PubMed ID: 20886217
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Yekkala K; Baudino TA
Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
[TBL] [Abstract][Full Text] [Related]
19. Effect of epidermal growth factor administration on intestinal cell proliferation, crypt fission and polyp formation in multiple intestinal neoplasia (Min) mice.
Bashir O; Fitzgerald AJ; Berlanga-Acosta J; Playford RJ; Goodlad RA
Clin Sci (Lond); 2003 Sep; 105(3):323-30. PubMed ID: 12749762
[TBL] [Abstract][Full Text] [Related]
20. Cysteinyl leukotriene 1 receptor influences intestinal polyp incidence in a gender-specific manner in the ApcMin/+ mouse model.
Savari S; Chandrashekar NK; Osman J; Douglas D; Bellamkonda K; Jönsson G; Juhas M; Greicius G; Pettersson S; Sjölander A
Carcinogenesis; 2016 May; 37(5):491-9. PubMed ID: 26979937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
